甲雷克萨特治疗中度至重度牛皮的代谢变化
Yi Zhou1,2,3, Yantao Ding1,2,3, Mengxing Cui4
1Department of Dermatology and Venereology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China (mainland).
概括
牛皮涉及脂质代谢的改变,在甲醇治疗后,特定的甘油三和脂物发生变化. 这些脂质配置文件可以表明治疗反应和疾病发病年龄.
科学领域:
- 皮肤病学 皮肤病学
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 异常的脂质代谢与牛皮病原发生有关.
- 了解牛皮的脂质变化对于治疗和诊断至关重要.
研究的目的:
- 为了研究与牛皮相关的脂质代谢物.
- 探索脂质概况与疾病发病年龄之间的关系.
- 为了评估在甲状腺素治疗前后的脂质代谢物变化.
主要方法:
- 对96名中度至重度牛皮患者的血清代谢分析.
- 多变量统计分析用于比较脂质资料.
- 基于甲状腺素 (MTX) 治疗反应 (PASI 75) 和发病年龄的患者分层.
主要成果:
- 检测到1546种脂质代谢物,其中甘油三 (TG),脂 (PE) 和酸胆 (PC) 是最丰富的.
- 特定的TG和溶解脂胆 (LPC) 水平在MTX治疗后显著变化.
- 甲基乙醇胺 (PE) 变体 (PE 34:4,PE 38:1) 在MTX反应者和不反应者之间有所不同.
- 在早期 (<40岁) 和晚期 (≥40岁) 牛皮之间观察到脂质代谢的差异.
- 滴糖类 (DG) 与发病年龄相关.
结论:
- 葡萄糖脂代谢途径与牛皮有关.
- 血清脂质概况在MTX治疗中发生显著变化.
- 响应者的特定脂质水平变化可以预测MTX治疗的疗效.
相关概念视频
Phase II Reactions: Methylation Reactions
180
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
180
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158


